Eye Care in Denmark
Euromonitor International's Eye Care in Denmark market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 33 | Publication date: Oct 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Allergy eye care; Antibiotic eye care; Standard eye care
Table of contents
EYE CARE IN DENMARK : MARKET INSIGHT
SECTOR DATA
Table 1 Sales of Eye Care by Subsector: Value 2003-2008
Table 2 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 3 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 4 Eye Care Company Shares by Value 2004-2008
Table 5 Eye Care Brand Shares by Value 2005-2008
Table 6 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 7 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - DENMARK
ACTAVIS A/S - OTC HEALTHCARE - DENMARK
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Actavis Nordic A/S: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 Actavis Nordic A/S: Competitive Position 2008
CEDERROTH A/S - OTC HEALTHCARE - DENMARK
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Cederroth A/S: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Cederroth A/S: Competitive Position 2008
FERROSAN A/S - OTC HEALTHCARE - DENMARK
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Ferrosan A/S: Key Facts
Summary 6 Ferrosan A/S: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 7 Ferrosan A/S: Competitive Position 2008
NYCOMED DANMARK A/S - OTC HEALTHCARE - DENMARK
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Nycomed Danmark A/S: Key Facts
Summary 9 Nycomed Group: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Nycomed Danmark A/S: Competitive Position 2008
ORIFARM A/S - OTC HEALTHCARE - DENMARK
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Orifarm A/S: Key Facts
Summary 12 Orifarm Group: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Orifarm A/S: Competitive Position 2008
OTC HEALTHCARE IN DENMARK
EXECUTIVE SUMMARY
Strong market performance in 2008
Convenience is a key growth driver
Leading multinationals and vitamin and dietary supplement manufacturers performed best
Pharmacies and drugstores lost share
Strong growth to continue during forecast period
KEY TRENDS AND DEVELOPMENTS
Liberalisation process slows down
Consolidation strategies begin to bear fruit
Trend towards generics and parallel imports continues
Convenience is a key consumer trend
Long-term decline in public health is a key demand driver
Boom in internet sales continues
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 9 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 10 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 11 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 12 OTC Healthcare Company Shares by Value 2004-2008
Table 13 OTC Healthcare Brand Shares by Value 2005-2008
Table 14 Penetration of Private Label by Sector 2003-2008
Table 15 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 16 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 17 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 18 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU LEGISLATION
European regulatory systems
Marketing authorisations
Distribution
Pricing
Switch Climate
Centralised procedure
Regulation of vitamins and dietary supplements
Regulation of herbal products
Self-medication and Preventative Medicine
Generics
Switches
Summary 14 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 15 Research Sources